Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration with CSL Seqirus, U.S. BARDA for ...

Taylor Swift isn’t through with her showgirl era just yet. The pop star just released the music video for her next The Life of a Showgirl single, “Opalite” — and it’s full of lightning-strike twists.

This music was commissioned by Robtop Games and made for Geometry Dash to be a custom level for the community. I decided to make a full version of it too! For other Geometry Dash music from me, check ...

Since publishing our first article in July of 2009, DualShockers has become an established name in the video game industry. What initially set out to be a means of “getting into E3” has transformed ...

Arcturus Therapeutics Public Relations & Investor Relations Neda Safarzadeh VP, Head of IR/PR/Marketing (858) 900-2682 IR@ArcturusRx.com Source: Arcturus Therapeutics Holdings Inc. The views and ...

Brianna Tobritzhofer is a nationally credentialed Registered Dietitian and experienced health writer with over a decade of leadership in nutrition program development, policy compliance, and public ...

Payne indicated that the company intends to "evaluate daily dosing of ARCT-032 over a 12-week duration in up to 20 CF participants," with this study planned to begin in the first half of 2026. He ...

Maybe it’s just me, but Stella Donnelly’s music has always carried the faint scent of Christmas. Not the department-store kind with Slade blaring and plastic reindeer grinning in shop windows, but ...

The MarketWatch News Department was not involved in the creation of this content. PHILADELPHIA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (Nasdaq: DVLT), a leader in AI-driven ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) stock was trading lower on Wednesday after the company shared interim results from its ongoing Phase 2 trial of ARCT-032, an investigational inhaled ...

In a mixed interim data drop, Arcturus Therapeutics has revealed a lack of efficacy for its investigational inhaled mRNA therapy in cystic fibrosis (CF). The findings, shared today before market open, ...